0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Stem Cell Therapy Market Research Report 2026
Published Date: 2026-01-15
|
Report Code: QYRE-Auto-15G12943
Home | Market Reports
Global Stem Cell Therapy Sales Market Report 2023
BUY CHAPTERS

Global Stem Cell Therapy Market Research Report 2026

Code: QYRE-Auto-15G12943
Report
2026-01-15
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Stem Cell Therapy Market Size

The global Stem Cell Therapy market was valued at US$ 807 million in 2025 and is anticipated to reach US$ 2793 million by 2032, at a CAGR of 19.7% from 2026 to 2032.

Stem Cell Therapy Market

Stem Cell Therapy Market

Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.
The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson’s disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).
This report delivers a comprehensive overview of the global Stem Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy. The Stem Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Stem Cell Therapy Market Report

Report Metric Details
Report Name Stem Cell Therapy Market
Accounted market size in 2025 US$ 807 million
Forecasted market size in 2032 US$ 2793 million
CAGR 19.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Allogeneic Stem Cell Therapies
  • Autologous Stem Cell Therapies
Segment by Application
  • Neurodegenerative Diseases
  • Cardiovascular Disorders
  • Autoimmune Conditions
  • Orthopedic Injuries
  • Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medipost, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Regeneus, Bluebird bio, Inc, NIPRO, Kyowa Kirin, CorestemChemon Inc., ANTEROGEN.CO., LTD., Holostem, NuVasive, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Takeda (TiGenix)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Stem Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Stem Cell Therapy Market growing?

Ans: The Stem Cell Therapy Market witnessing a CAGR of 19.7% during the forecast period 2026-2032.

What is the Stem Cell Therapy Market size in 2032?

Ans: The Stem Cell Therapy Market size in 2032 will be US$ 2793 million.

Who are the main players in the Stem Cell Therapy Market report?

Ans: The main players in the Stem Cell Therapy Market are Medipost, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Regeneus, Bluebird bio, Inc, NIPRO, Kyowa Kirin, CorestemChemon Inc., ANTEROGEN.CO., LTD., Holostem, NuVasive, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Takeda (TiGenix)

What are the Application segmentation covered in the Stem Cell Therapy Market report?

Ans: The Applications covered in the Stem Cell Therapy Market report are Neurodegenerative Diseases, Cardiovascular Disorders, Autoimmune Conditions, Orthopedic Injuries, Cancer, Others

What are the Type segmentation covered in the Stem Cell Therapy Market report?

Ans: The Types covered in the Stem Cell Therapy Market report are Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Allogeneic Stem Cell Therapies
1.2.3 Autologous Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Disorders
1.3.4 Autoimmune Conditions
1.3.5 Orthopedic Injuries
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2021–2032)
2.2 Global Stem Cell Therapy Growth Trends by Region
2.2.1 Global Stem Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Stem Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Stem Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2025
3.5 Global Key Players of Stem Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Stem Cell Therapy, Products and Applications
3.7 Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Stem Cell Therapy Market Size (2021–2032)
6.2 North America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Stem Cell Therapy Market Size by Country (2021–2026)
6.4 North America Stem Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2021–2032)
7.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Stem Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Stem Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Stem Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2021–2032)
9.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Stem Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Stem Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy Business (2021–2026)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2021–2026)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy Business (2021–2026)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy Business (2021–2026)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy Business (2021–2026)
11.5.5 Regeneus Recent Development
11.6 Bluebird bio, Inc
11.6.1 Bluebird bio, Inc Company Details
11.6.2 Bluebird bio, Inc Business Overview
11.6.3 Bluebird bio, Inc Stem Cell Therapy Introduction
11.6.4 Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2021–2026)
11.6.5 Bluebird bio, Inc Recent Development
11.7 NIPRO
11.7.1 NIPRO Company Details
11.7.2 NIPRO Business Overview
11.7.3 NIPRO Stem Cell Therapy Introduction
11.7.4 NIPRO Revenue in Stem Cell Therapy Business (2021–2026)
11.7.5 NIPRO Recent Development
11.8 Kyowa Kirin
11.8.1 Kyowa Kirin Company Details
11.8.2 Kyowa Kirin Business Overview
11.8.3 Kyowa Kirin Stem Cell Therapy Introduction
11.8.4 Kyowa Kirin Revenue in Stem Cell Therapy Business (2021–2026)
11.8.5 Kyowa Kirin Recent Development
11.9 CorestemChemon Inc.
11.9.1 CorestemChemon Inc. Company Details
11.9.2 CorestemChemon Inc. Business Overview
11.9.3 CorestemChemon Inc. Stem Cell Therapy Introduction
11.9.4 CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2021–2026)
11.9.5 CorestemChemon Inc. Recent Development
11.10 ANTEROGEN.CO., LTD.
11.10.1 ANTEROGEN.CO., LTD. Company Details
11.10.2 ANTEROGEN.CO., LTD. Business Overview
11.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Introduction
11.10.4 ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2021–2026)
11.10.5 ANTEROGEN.CO., LTD. Recent Development
11.11 Holostem
11.11.1 Holostem Company Details
11.11.2 Holostem Business Overview
11.11.3 Holostem Stem Cell Therapy Introduction
11.11.4 Holostem Revenue in Stem Cell Therapy Business (2021–2026)
11.11.5 Holostem Recent Development
11.12 NuVasive
11.12.1 NuVasive Company Details
11.12.2 NuVasive Business Overview
11.12.3 NuVasive Stem Cell Therapy Introduction
11.12.4 NuVasive Revenue in Stem Cell Therapy Business (2021–2026)
11.12.5 NuVasive Recent Development
11.13 JCR Pharmaceutical
11.13.1 JCR Pharmaceutical Company Details
11.13.2 JCR Pharmaceutical Business Overview
11.13.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.13.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2021–2026)
11.13.5 JCR Pharmaceutical Recent Development
11.14 Pharmicell
11.14.1 Pharmicell Company Details
11.14.2 Pharmicell Business Overview
11.14.3 Pharmicell Stem Cell Therapy Introduction
11.14.4 Pharmicell Revenue in Stem Cell Therapy Business (2021–2026)
11.14.5 Pharmicell Recent Development
11.15 Medi-post
11.15.1 Medi-post Company Details
11.15.2 Medi-post Business Overview
11.15.3 Medi-post Stem Cell Therapy Introduction
11.15.4 Medi-post Revenue in Stem Cell Therapy Business (2021–2026)
11.15.5 Medi-post Recent Development
11.16 Anterogen
11.16.1 Anterogen Company Details
11.16.2 Anterogen Business Overview
11.16.3 Anterogen Stem Cell Therapy Introduction
11.16.4 Anterogen Revenue in Stem Cell Therapy Business (2021–2026)
11.16.5 Anterogen Recent Development
11.17 Takeda (TiGenix)
11.17.1 Takeda (TiGenix) Company Details
11.17.2 Takeda (TiGenix) Business Overview
11.17.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.17.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2021–2026)
11.17.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Allogeneic Stem Cell Therapies
 Table 3. Key Players of Autologous Stem Cell Therapies
 Table 4. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Stem Cell Therapy Market Share by Region (2021–2026)
 Table 8. Global Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Stem Cell Therapy Market Share by Region (2027–2032)
 Table 10. Stem Cell Therapy Market Trends
 Table 11. Stem Cell Therapy Market Drivers
 Table 12. Stem Cell Therapy Market Challenges
 Table 13. Stem Cell Therapy Market Restraints
 Table 14. Global Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Stem Cell Therapy Market Share by Players (2021–2026)
 Table 16. Global Top Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cell Therapy Revenue, 2025
 Table 17. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Stem Cell Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Stem Cell Therapy, Products and Applications
 Table 21. Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Stem Cell Therapy Revenue Market Share by Type (2021–2026)
 Table 25. Global Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Stem Cell Therapy Revenue Market Share by Type (2027–2032)
 Table 27. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Stem Cell Therapy Revenue Market Share by Application (2021–2026)
 Table 29. Global Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Stem Cell Therapy Revenue Market Share by Application (2027–2032)
 Table 31. North America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 46. Medipost Company Details
 Table 47. Medipost Business Overview
 Table 48. Medipost Stem Cell Therapy Product
 Table 49. Medipost Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 50. Medipost Recent Development
 Table 51. Theracell Advanced Biotechnology Company Details
 Table 52. Theracell Advanced Biotechnology Business Overview
 Table 53. Theracell Advanced Biotechnology Stem Cell Therapy Product
 Table 54. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 55. Theracell Advanced Biotechnology Recent Development
 Table 56. Nature Cell Company Details
 Table 57. Nature Cell Business Overview
 Table 58. Nature Cell Stem Cell Therapy Product
 Table 59. Nature Cell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 60. Nature Cell Recent Development
 Table 61. Stempeutics Company Details
 Table 62. Stempeutics Business Overview
 Table 63. Stempeutics Stem Cell Therapy Product
 Table 64. Stempeutics Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 65. Stempeutics Recent Development
 Table 66. Regeneus Company Details
 Table 67. Regeneus Business Overview
 Table 68. Regeneus Stem Cell Therapy Product
 Table 69. Regeneus Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 70. Regeneus Recent Development
 Table 71. Bluebird bio, Inc Company Details
 Table 72. Bluebird bio, Inc Business Overview
 Table 73. Bluebird bio, Inc Stem Cell Therapy Product
 Table 74. Bluebird bio, Inc Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 75. Bluebird bio, Inc Recent Development
 Table 76. NIPRO Company Details
 Table 77. NIPRO Business Overview
 Table 78. NIPRO Stem Cell Therapy Product
 Table 79. NIPRO Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 80. NIPRO Recent Development
 Table 81. Kyowa Kirin Company Details
 Table 82. Kyowa Kirin Business Overview
 Table 83. Kyowa Kirin Stem Cell Therapy Product
 Table 84. Kyowa Kirin Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 85. Kyowa Kirin Recent Development
 Table 86. CorestemChemon Inc. Company Details
 Table 87. CorestemChemon Inc. Business Overview
 Table 88. CorestemChemon Inc. Stem Cell Therapy Product
 Table 89. CorestemChemon Inc. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 90. CorestemChemon Inc. Recent Development
 Table 91. ANTEROGEN.CO., LTD. Company Details
 Table 92. ANTEROGEN.CO., LTD. Business Overview
 Table 93. ANTEROGEN.CO., LTD. Stem Cell Therapy Product
 Table 94. ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 95. ANTEROGEN.CO., LTD. Recent Development
 Table 96. Holostem Company Details
 Table 97. Holostem Business Overview
 Table 98. Holostem Stem Cell Therapy Product
 Table 99. Holostem Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 100. Holostem Recent Development
 Table 101. NuVasive Company Details
 Table 102. NuVasive Business Overview
 Table 103. NuVasive Stem Cell Therapy Product
 Table 104. NuVasive Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 105. NuVasive Recent Development
 Table 106. JCR Pharmaceutical Company Details
 Table 107. JCR Pharmaceutical Business Overview
 Table 108. JCR Pharmaceutical Stem Cell Therapy Product
 Table 109. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 110. JCR Pharmaceutical Recent Development
 Table 111. Pharmicell Company Details
 Table 112. Pharmicell Business Overview
 Table 113. Pharmicell Stem Cell Therapy Product
 Table 114. Pharmicell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 115. Pharmicell Recent Development
 Table 116. Medi-post Company Details
 Table 117. Medi-post Business Overview
 Table 118. Medi-post Stem Cell Therapy Product
 Table 119. Medi-post Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 120. Medi-post Recent Development
 Table 121. Anterogen Company Details
 Table 122. Anterogen Business Overview
 Table 123. Anterogen Stem Cell Therapy Product
 Table 124. Anterogen Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 125. Anterogen Recent Development
 Table 126. Takeda (TiGenix) Company Details
 Table 127. Takeda (TiGenix) Business Overview
 Table 128. Takeda (TiGenix) Stem Cell Therapy Product
 Table 129. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
 Table 130. Takeda (TiGenix) Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Stem Cell Therapy Picture
 Figure 2. Global Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Stem Cell Therapy Market Share by Type: 2025 vs 2032
 Figure 4. Allogeneic Stem Cell Therapies Features
 Figure 5. Autologous Stem Cell Therapies Features
 Figure 6. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Stem Cell Therapy Market Share by Application: 2025 vs 2032
 Figure 8. Neurodegenerative Diseases Case Studies
 Figure 9. Cardiovascular Disorders Case Studies
 Figure 10. Autoimmune Conditions Case Studies
 Figure 11. Orthopedic Injuries Case Studies
 Figure 12. Cancer Case Studies
 Figure 13. Others Case Studies
 Figure 14. Stem Cell Therapy Report Years Considered
 Figure 15. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Stem Cell Therapy Market Share by Region: 2025 vs 2032
 Figure 18. Global Stem Cell Therapy Market Share by Players in 2025
 Figure 19. Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2025
 Figure 21. North America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 23. United States Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 27. Germany Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Stem Cell Therapy Market Share by Region (2021–2032)
 Figure 35. China Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 43. Mexico Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Stem Cell Therapy Market Share by Country (2021–2032)
 Figure 47. Israel Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Medipost Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 51. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 52. Nature Cell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 53. Stempeutics Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 54. Regeneus Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 55. Bluebird bio, Inc Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 56. NIPRO Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 57. Kyowa Kirin Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 58. CorestemChemon Inc. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 59. ANTEROGEN.CO., LTD. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 60. Holostem Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 61. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 62. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 63. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 64. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 65. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 66. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD